Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03ODQ
|
|||
| Former ID |
DNC004442
|
|||
| Drug Name |
[1,4]Oxazepan-(5E)-ylideneamine
|
|||
| Synonyms |
CHEMBL330548; [1,4]Oxazepan-(5E)-ylideneamine; SCHEMBL2590253; 5-Iminohexahydro-1,4-oxazepine; [1,4]Oxazepan-(5Z)-ylideneamine; BDBM50104659
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H10N2O
|
|||
| Canonical SMILES |
C1COCCN=C1N
|
|||
| InChI |
1S/C5H10N2O/c6-5-1-3-8-4-2-7-5/h1-4H2,(H2,6,7)
|
|||
| InChIKey |
IJBIVIJNRYYPRZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis of analogs of (1,4)-3- and 5-imino oxazepane, thiazepane, and diazepane as inhibitors of nitric oxide synthases. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5907-11. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.